Journals / Klimik Dergisi / 2017 / Cilt: 30 - Sayı: 3

Severe Hyponatremia During Moxifloxacin Treatment: A Case Report

Moksifloksasin Tedavisi Sırasında Gelişen Ciddi Hiponatremi: Bir Olgu Sunumu

Pages
59–60
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It should be kept in mind that hyponatremia may develop during the use of moxifloxacin, especially in patients with additional risk factors.Klimik Dergisi 2017; 30(3): 153-4

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this report, a case of severe hyponatremia associated with moxifloxacin is presented.
📊
Key Findings & Data:On the first day of hospitalization, blood sodium was 141 mmol/L.
💡
Conclusion & Impact:It should be kept in mind that hyponatremia may develop during the use of moxifloxacin, especially in patients with additional risk factors.Klimik Dergisi 2017; 30(3): 153-4
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

In this report, a case of severe hyponatremia associated with moxifloxacin is presented. A ninety-year-old woman was hospitalized with pneumonia. On the first day of hospitalization, blood sodium was 141 mmol/L. Persistent hyponatremia (123127 mmol/L) began in the second day of moxifloxacin therapy. It did not improve despite the use of hypertonic fluids throughout the two-week treatment. The therapy was discontinued on the 13th day with moxifloxacin as the cause of hyponatremia in mind. Next day, the blood sodium of 127 mmol/L was detected. Gradually increasing levels were monitored and one week after discontinuation of therapy normal results were obtained. It should be kept in mind that hyponatremia may develop during the use of moxifloxacin, especially in patients with additional risk factors.Klimik Dergisi 2017; 30(3): 153-4

Özet

Bu yazıda moksifloksasinle ilişkili olabileceği düşünülen ciddi hiponatremili bir olgu sunulmaktadır. Doksan yaşında kadın hasta pnömoni tanısıyla servise yatırıldı. İlk gün ölçülen sodyum 141 mmol/lt idi. Pnömoni nedeniyle başlanan moksifloksasin tedavisinin ikinci gününde başlayıp iki haftalık tedavi boyunca hipertonik sıvı verilmesine rağmen düzelmeyen inatçı hiponatremi (123 ve 127 mmol/lt arasında değerler) tespit edilmiştir. Tedavinin 13. gününde hiponatreminin moksifloksasin kaynaklı olabileceği düşünülüp tedavi kesilmiş ve ertesi gün alınan kan örneğinde sodyum 127 mmol/lt olarak tespit edilmiştir. Giderek artan düzeyler izlenmiş ve tedavinin kesilmesinden bir hafta sonra normal sonuçlar elde edilmiştir. Özellikle ek risk faktörlerine sahip hastalarda, moksifloksasin kullanımı sırasında hiponatremi gelişebileceği akılda tutulmalıdır.Klimik Dergisi 2017; 30(3): 153-4

🔖

Cite This Article

ADEMOĞLU, D., ŞEKER, R., SERT, A. Ş. (2022). Severe Hyponatremia During Moxifloxacin Treatment: A Case Report. Klimik Dergisi, Cilt: 30 - Sayı: 3, 59–60. https://ajindex.com/articles/564020

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol. 2007; 292(5): F1652-6
  2. Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987; 83(5): 905-8
  3. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342(21): 1581-9
  4. Soupart A, Gross P, Legros JJ, et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol. 2006; 1(6): 1154-60
  5. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007; 120(11 Suppl. 1): S1-21
  6. Vaidya C, Ho W, Freda BJ. Management of hyponatremia: providing treatment and avoiding harm. Cleve Clin J Med. 2010; 77(10): 715-26
  7. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med. 1988; 318(7): 397-403
  8. Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry. 1979; 136(2): 221-2
  9. Peters HP, Robben JH, Deen PM, Wetzels JF. Water in health and disease: new aspects of disturbances in water metabolism. Neth J Med. 2007; 65(9): 325-32
  10. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008; 52(1): 144-53
  11. Adler D, Voide C, Thorens JB, Desmeules J. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med. 2004; 15(7): 463-4
  12. Naranjo CA, Busto U, Sellers EM. Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatr. 1982; 6(4-6): 651-7
  13. Müssig K, Schnauder G, Mörike K. Severe and symptomatic hyponatraemia after moxifloxacin intake. Neth J Med. 2009; 67(5): 197.